Showing results (691-700 of 3,636) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|October 18, 2016
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatmentLaura Orlando, Giuseppe Viale, Emilio Bria, et al.
Breast (Edinburgh, Scotland)|November 22, 2016
Factors influencing local control in patients undergoing breast conservation surgery for ductal carcinoma in situJ Mathew, R Karia, D A L Morgan, et al.
Breast (Edinburgh, Scotland)|May 27, 2008
Improved safety of autologous breast reconstruction surgery by stabilisation of microsurgical vessel anastomoses using fibrin sealant in 349 free DIEP or fascia-muscle-sparing (fms)-TRAM flaps: a two-centre studyChristoph Andree, Beatrix I J Munder, Philipp Behrendt, et al.
Breast (Edinburgh, Scotland)|May 30, 2008
Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancerBarbro K Linderholm, Sofia Gruvberger-Saal, Sofia Gruvbreger-Saal, et al.
Breast (Edinburgh, Scotland)|June 7, 2008
Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observationsHe Liu, Yu-Xin Jiang, Ji-Bin Liu, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-upRoberto Agresti, Flavio Crippa, Marco Sandri, et al.
Breast (Edinburgh, Scotland)|March 5, 2014
The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancerEva Ciruelos, Tomás Pascual, María Luisa Arroyo Vozmediano, et al.
Breast (Edinburgh, Scotland)|November 18, 2018
Risk of cardiac disease after adjuvant radiation therapy among breast cancer survivorsJee Suk Chang, Jaeyong Shin, Eun-Cheol Park, et al.
Breast (Edinburgh, Scotland)|October 19, 2018
ErbB4 receptor polymorphism 2368A>C and risk of breast cancerMasoumeh Mansouri Bidkani, Hossein Tabatabaeian, Soha Parsafar, et al.
Breast (Edinburgh, Scotland)|October 21, 2018
Ribociclib in hormone-receptor-positive advanced breast cancer: Establishing a value-based cost in ChinaXiaoMin Wan, YuCong Zhang, JinAn Ma, et al.
Pageof 364